reiterateCINTfinnhub
TD Cowen Reiterates Buy Rating on CI&T Inc (CINT)
TD Cowen reiterated its Buy rating on CI&T Inc (NYSE:CINT) on August 12, 2026.
Read moreFeatured By
Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
TD Cowen reiterated its Buy rating on CI&T Inc (NYSE:CINT) on August 12, 2026.
Read moreTruist Securities reiterated its Buy rating on Riley Exploration Permian, Inc. (AMEX:REPX) on August 12, 2026.
Read moreNeedham reiterated its Buy rating on Kornit Digital Ltd. (NASDAQ:KRNT) on August 12, 2026.
Read moreWells Fargo reiterated its Equal-Weight rating on Claritev Corporation (NYSE:CTEV) on August 12, 2026.
Read moreNorthland Capital Markets analysts upgraded Similarweb Ltd. (NYSE:SMWB) from Market Perform to Outperform on August 12, 2026.
Read moreNeedham reiterated its Buy rating on Ambiq Micro, Inc. (NYSE:AMBQ) on August 12, 2026.
Read moreUBS reiterated its Neutral rating on Ambiq Micro, Inc. (NYSE:AMBQ) on August 12, 2026.
Read moreGuggenheim reiterated its Buy rating on Tango Therapeutics, Inc. (NASDAQ:TNGX) on August 12, 2026.
Read moreBTIG reiterated its Buy rating on Bicara Therapeutics Inc. Common Stock (NASDAQ:BCAX) on August 12, 2026.
Read moreWells Fargo reiterated its Equal-Weight rating on Bicara Therapeutics Inc. Common Stock (NASDAQ:BCAX) on August 12, 2026.
Read moreMizuho reiterated its Neutral rating on Bicara Therapeutics Inc. Common Stock (NASDAQ:BCAX) on August 12, 2026.
Read moreGoldman Sachs reiterated its Neutral rating on Bicara Therapeutics Inc. Common Stock (NASDAQ:BCAX) on August 12, 2026.
Read moreMorgan Stanley reiterated its Overweight rating on Bicara Therapeutics Inc. Common Stock (NASDAQ:BCAX) on August 12, 2026.
Read moreSusquehanna reiterated its Neutral rating on Rapid7, Inc. (NASDAQ:RPD) on August 12, 2026.
Read moreCanaccord Genuity reiterated its Hold rating on Rapid7, Inc. (NASDAQ:RPD) on August 12, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Rapport Therapeutics, Inc.
Read moreTD Cowen reiterated its Hold rating on Calumet, Inc. (NASDAQ:CLMT) on August 12, 2026.
Read moreTruist Securities reiterated its Buy rating on Immunome, Inc. (NASDAQ:IMNM) on August 12, 2026.
Read moreWedbush reiterated its Outperform rating on Immunome, Inc. (NASDAQ:IMNM) on August 12, 2026.
Read moreJP Morgan reiterated its Overweight rating on Helios Technologies, Inc. (NYSE:HLIO) on August 12, 2026.
Read more